Director/PDMR Shareholding-Re

RNS Number : 1550W

GlaxoSmithKline PLC

06 June 2008

 



This announcement replaces the announcement released on 18 April 2008 at 14:58, RNS No: 6831S.

The Administrators of the accounts of the under-mentioned persons advised the Company on 5 June 2008 of a correction to the number of Ordinary dividends re-invested on 10 April 2008 in respect of the under-mentioned persons.

All other details remain unchanged.

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of an increase in interests in Ordinary shares at a price of £10.73 per share and Ordinary share ADRs at a price of $43.32 per ADR in GlaxoSmithKline plc in respect of the personal holdings of the under-mentioned persons, following the re-investment of the dividend paid to shareholders on 10 April 2008.

	Ordinary shares	ADRs
Dr M M Slaoui	28.86
Mrs C E Bruck Slaoui	16.49
Mr EJ Gray	29.47
Mr D Learmouth	27.80
Mr W C Louv		14.19
Mr S M Werner		14.47

The Company and the above named persons were advised of this information on 18 April 2008.

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

S M Bicknell

Company Secretary

18 April 2008

 

END

 

 

RDSKGGGVLVNGRZG